Table 5.
clinical features of published case reports of microbial keratitis in pediatric patients.
| Author and year | Patient’s age and gender | CXL protocol and Laterality | CDVA at presentation | Time after procedure | Organism | Final CDVA |
|---|---|---|---|---|---|---|
|
| ||||||
| Sharma et al 2010109 | 19 y/o female | S- CXL | Hand motions near to face | 1 day | Pseudomonas aeruginosa | 20/200 |
| OD | ||||||
|
| ||||||
| Shetty et al 2014110 | 18 y/o male | S- CXL | N/A | 3 days | Staphylococcus aureus | 20/30 |
|
| ||||||
| Al-Qarni et al 2015107 | 18 y/o male | S-CXL | N/A | 7 days | Herpes Simplex | 20/25 |
| OS | ||||||
|
| ||||||
| Rana et al 2015108 | 19 y/o female | Trans epithelial | N/A | 3 days | Staphylococcus aureus | N/A |
| Accelerated CXL | ||||||
| (9 mW/Cm2 × 10 min) | ||||||
| OS | ||||||
|
| ||||||
| 18 y/o male | Epithelium off | N/A | 5 days | Methicilin resistant Staphylococcus aureus | 20/70 | |
| Accelerated CXL | ||||||
| (9 mW/Cm2 × 10 min) | ||||||
| OD | ||||||
|
| ||||||
| Kodavoor et al 2015111 | 15 y/o male | Accelerated CXL | 20/400 | 3 days | Staphylococcus aureus | 20/40 |
| (30 mW/Cm2 × 3 min) | ||||||
| OD | ||||||
S-CXL: Standard Crosslinking